Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.
about
EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.Lipoxins: nature's way to resolve inflammationEpstein-Barr virus and the origin of Hodgkin lymphomaEpstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesisDe novo infection with rhesus monkey rhadinovirus leads to the accumulation of multiple intranuclear capsid species during lytic replication but favors the release of genome-containing virions.An in vitro system for studying murid herpesvirus-4 latency and reactivation.IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoterDown-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphomaLMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.Epstein-Barr virus BGLF4 kinase downregulates NF-κB transactivation through phosphorylation of coactivator UXT.The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuliSignal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes.NF-κB as a target for oncogenic viruses.Switching of EBV cycles between latent and lytic states.Regulation of Epstein-Barr virus reactivation from latency.The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitorsEpstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds.Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray.Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.Epstein-Barr virus latent membrane protein 1 (LMP-1) half-life in epithelial cells is down-regulated by lytic LMP-1.Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production.The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes.(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.
P2860
Q24804219-9522B1F9-3BAB-4009-95E9-B243DCA2F955Q26784376-C458DD47-F619-46E1-930F-83FE8C5E9879Q26998999-D49437BF-8E77-4288-88E2-8FB80138DD14Q28079510-1433DBAE-9091-4C8C-8781-A2A25DA533EFQ30311978-8E7BF28F-CEF5-41D0-A0DD-625EDC437557Q33605765-FB3D90D4-95C1-4C2C-95B3-1EDA3F7AC0B2Q33640213-4EA48701-CC41-4590-8AD4-14D96469076DQ33754919-020BD49B-E280-4399-A651-49F4CC587C91Q33923073-C5914F85-270A-4E05-B161-A1CDDF89050FQ34627655-A63817DB-C44B-4088-B9C9-350AC066F021Q34650591-5412B2AB-3CF1-4725-9F95-1212CA4EBE61Q35242466-31FB652E-EA4D-47A6-83DD-0F4FCF021D61Q35641151-564E4377-1147-46D7-B9B2-5AC1F0C759FFQ35847814-076E1198-4B06-4C61-977C-492BE33320D5Q35861199-D8182D2F-197E-4500-87D9-C52B94967F23Q36171933-B7431F7B-9500-4499-8543-2B0E15ED53EBQ36363901-FFD931F4-0770-4625-B451-58F046746237Q36414572-91BAE8BD-2EEE-484D-8E44-8940E88A1744Q37252690-C227CAA2-01A9-4D5F-A89D-3FD336A27DF7Q37374081-E78D7551-99EE-49F1-AF88-B49DAF3A7029Q38171455-81173B98-1C34-4BD8-9960-27F75D61776BQ38208532-D7120FF4-FCA9-475B-8EFF-F6602C7060E4Q39344275-3CC52C5E-E7DB-462E-A384-4A97CE4DD9D1Q39778922-69F2FE33-61DE-446F-952E-1B3736225307Q39789708-E4C12DEA-1A8E-441E-BC0F-BD647179038BQ39875400-79AA3296-B043-4B9F-B11C-5AA24FB5CE36Q40155828-F78488FC-A761-44E2-9F72-F9113A1A66C8Q40271086-4EB66C25-C750-4210-B548-4B9653C8A0F8Q40339509-82AA9746-D2AE-4F2A-8392-2212AD85AEB8Q41039085-597D7308-C05F-4D21-AFB0-B6C881331BACQ41808994-A7D77984-71AF-4602-95E2-7B42C000E35AQ44713676-52994C28-B4FC-43C6-ABD5-8A97A7E040D8Q49202700-B2514BD9-0F3E-490A-BF06-AF1B02E41827
P2860
Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Latent membrane protein 1 inhi ...... ress via different mechanisms.
@ast
Latent membrane protein 1 inhi ...... ress via different mechanisms.
@en
Latent membrane protein 1 inhi ...... ress via different mechanisms.
@nl
type
label
Latent membrane protein 1 inhi ...... ress via different mechanisms.
@ast
Latent membrane protein 1 inhi ...... ress via different mechanisms.
@en
Latent membrane protein 1 inhi ...... ress via different mechanisms.
@nl
prefLabel
Latent membrane protein 1 inhi ...... ress via different mechanisms.
@ast
Latent membrane protein 1 inhi ...... ress via different mechanisms.
@en
Latent membrane protein 1 inhi ...... ress via different mechanisms.
@nl
P2093
P2860
P1433
P1476
Latent membrane protein 1 inhi ...... gress via different mechanisms
@en
P2093
Eike Floettmann
Paul Brennan
Sinead Keating
Stuart Prince
P2860
P304
P356
10.1128/JVI.77.8.5000-5007.2003
P407
P577
2003-04-01T00:00:00Z